+987.9%
MRNA vs GH
+80.5%
+907.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -3.7% | +16.8% | +15.1% |
| 7D | +20.6% | -7.7% | +28.3% | +25.6% |
| 30D | +27.1% | -10.0% | +37.1% | +34.4% |
| 3M | +353.4% | +5.5% | +347.9% | +342.2% |
| 6M | +446.3% | +84.9% | +361.4% | +338.1% |
| YTD | +776.2% | +65.0% | +711.1% | +620.2% |
| 1Y | +987.9% | +71.8% | +916.1% | +742.7% |
| All | +987.9% | +80.5% | +907.4% | +742.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling